International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)
672.00
-1.50 (-0.22%)
At close: Jul 8, 2022
International Medical Center of Biomaterials Processing and Cryostorage Company Description
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a personal stem cell storage bank in Russia.
The company is involved in the personal storage of stem cells and development of drugs for the treatment of blood and immune system diseases.
It stores biomaterial samples in its database for long-term personal storage, including samples of hematopoietic cord blood stem cells, as well as samples of mesenchymal stem cells and umbilical cord tissue for transplant.
The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company is a subsidiary of Artgen Biotech PJSC.
International Medical Center of Biomaterials Processing and Cryostorage
Country | Russia |
Founded | 2003 |
Industry | Miscellaneous Health And Allied Services, Not Elsewhere Classified |
Employees | 15 |
CEO | Prikhodko Viktorovich |
Contact Details
Address: Building 1 Moscow, 119333 Russia | |
Phone | 7 495 646 8076 |
Website | gemabank.ru |
Stock Details
Ticker Symbol | GEMA |
Exchange | Moscow Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | RUB |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Prikhodko Viktorovich | Chief Executive Officer |